We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

Mergers affect Boston biotech independence

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 21 2011

Biotech company executives meeting recently in Boston, were reportedly concerned about the growing buy-out trend among area businesses

Joint venture to create algae for biofuels

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • April 21 2011

Bard Holding Inc. and Algae Bioenergy Solutions (ABS) have announced a joint venture to develop an algae production facility in Augusta, Georgia

Chinese billionaire backs U.S.China biopharma venture

  • Shook Hardy & Bacon LLP
  • -
  • China, USA
  • -
  • April 21 2011

Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks

UK Takeover Panel poised to modify rules on hostile takeover bids

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 4 2010

The U.K. Panel on Takeovers and Mergers has announced that it plans to amend the Takeover Code to reduce the tactical advantage that hostile offerors have under the current code, particularly when short-term investors unduly influence the outcome of hostile offers to the detriment of the offeree company and its shareholders

Quebec establishes new venture capital fund to invest in biotech research

  • Shook Hardy & Bacon LLP
  • -
  • Canada
  • -
  • February 24 2011

Quebec's Charest administration has reportedly launched the third of three new venture capital funds to provide more than $41 million for investment in biotechnology research

Pharma merger activity attributed to “patent cliff”

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • November 18 2010

Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies

Sinochem Group announces joint venture with global life sciences company

  • Shook Hardy & Bacon LLP
  • -
  • Global
  • -
  • January 13 2011

Sinochem Group, a China-based oil and chemicals company, has announced an agreement with Royal DSM N.V., a Dutch global life sciences and material sciences company, to form a global anti-infective joint venture to be headquartered in Hong Kong

Court dismisses fraud claims against investors who sued biotech startup

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 7 2011

A federal court in California has granted in part the motion that two biotech startup investors filed under the state's anti-SLAPP (strategic lawsuit against public participation) law to dismiss the company's counterclaims against them

Venture investing decreased in California in 2010, but executives bullish about biotech future

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • February 7 2011

With biotechnology employing some 268,000 people in California, industryexecutives reportedly remain optimistic about its future in the state despitea recent report indicating that biotech venture investments decreased in 2010

Fewer small biotech companies go public

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • March 10 2011

Smaller biotechnology companies maneuvering through drug-development regulations are reportedly focusing their efforts on licensing products in development or selling their businesses to large pharmaceutical companies rather than pursuing an initial public offering (IPO

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy